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Abstract 
Antimicrobial resistance has become a major threat to mankind during the last century, no new 
antimicrobials have been discovered and pharmaceutical companies are no longer investing in the 
development of new antimicrobials. Due to the overuse and misuse of antibiotics, bacteria are 
evolving faster than ever. Research has shown that conventional antibiotics, that target specific 
enzymes, are becoming less effective, whereas amphiphilic antibiotics are still functional. This study 
aims at developing the efficacy of a novel class of amphiphilic compounds. Building on the work of 
Hiscock et al., DNA inspired amphiphiles, adenine analogue and thymine, were synthesised and its 
properties in the solid state, gas phase and solution state were studied. 
Analysis of the compounds shows that in the solid state, they tend to form extended structures 
with several binding modes and in the gas phase the low complex aggregates are visible, showing 
the strength of the interactions. In the solution state, the amphiphiles tend to form low complex 
species in DMSO, whereas in a H2O: EtOH 19:1 solution, the amphiphiles tend to form extended 
aggregates (> 100 nm). An investigation of 1:1 mixture of the adenine and thymine compounds was 
also carried out and the results show similar properties to the other compounds, however, the 
interactions between the amphiphiles were found to be weak. Antimicrobial screening of the 
amphiphiles and the mixture shows only the thymine inspired amphiphile inhibits bacterial growth. 
Based on these results, we can conclude the use of an analogue of adenine has impacted the 
strength of the complementary base pair interaction, therefore, the amphiphile will be 
resynthesised with a greater resemblance to adenine. 
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Jean-Marie Lehn coined the term supramolecular chemistry in 1987 during his Nobel Laureate 
lecture, he defined it as ‘chemistry beyond the molecule’.1 It is the study of the higher complex 
entities, formed by the result of non-covalent forces.2 Supramolecular chemistry is considered a 
young discipline, however, its concepts date back to the beginning of modern chemistry.  
Chemistry, as we know it today began when Friedrich Wöhler synthesised urea crystals from 
inorganic reactants.3 At the time, this was regarded as impossible as it did not obey the laws of 
vitalism;4 which states organic compounds could not be synthesised from inorganic components as 
it did not possess a certain energy required for life. Following this many other organic substances 
were synthesised without the use of organic reactants, disproving vitalism.5 Organic chemistry 
developed over the next few decades, however, the way the atoms were bonded still remained a 
controversial topic until 1916, where Gilbert N. Lewis proposed covalent bonding using a theory 
called ‘valence’ using a dot and cross diagram (Figure 1).6 Lewis theorised there were two types of 
covalent bonding; polar formed by the transfer of electrons and non-polar bonding formed by the 
sharing of electrons.7,8  
 
Figure 1 – Example of a dot and cross diagram to show a covalent bond in a water molecule. 
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1.2 Non-covalent interactions 
The intermolecular non-covalent interactions were first suggested in 1873 by Johannes Diderik 
van der Waals; a force between molecules which is now known as van der Waals interactions.9–11 
This led to, Emil Fischer proposing the lock and key principle for enzymes in 1894,12 stating that a 
specific substrate (key) is required to fit into the enzyme (lock), for the reaction to proceed (Figure 
2).  
 
Figure 2 – Illustration of the lock and key principle. The components are complimentary allowing them to bind together 
to form the final complex. 
Following this, Moore and Winmill hypothesised the presence of the hydrogen bond,13 which 
was further supported by Latimer and Rodebush.14 These concepts led to the synthesis of several 
host complexes that selectively bind to guest molecules; crown ether by Charles J. Pedersen,15 
macrocyclic cyclophanes by Donald J. Cram and cryptands by Jean-Marie Lehn (Figure 3).16,17 Over 
the past decade, supramolecular chemistry has become one of the fastest-growing fields of 
chemistry and has contributed to the development of nanotechnology, winning another noble prize 
for James Fraser Stoddart in 2016.18,19 
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Figure 3 – The series of host-guest complexes developed by Pedersen (crown ether), Lehn (cryptate) and Cram 
(spherand) respectively. 
Supramolecular complexes can self-organise or be preorganised. Preorganisation is where a 
molecule is designed to interact with a complementary molecule through non-covalent forces.20 
Whereas self-organisation is where the molecules assemble into higher ordered complex units 
through non-covalent interactions.21 A supermolecule can both self-organise and be designed to 
preorganise. 
The formation of a supramolecular complex is the result of a balance between electrostatic 
interactions and solvent interactions. There are many different types of non-covalent interaction, 
such as dipole-dipole interactions.22 Dipole-dipole interactions are the weakest types of 
interactions with energies of < 5 kJ/mol and are formed by the attraction of one dipole to another 
(Figure 4A).23 However, as the distance decreases the repulsive force between the electrons 
increase, therefore decreasing the energy and increasing the distance.24 π-π interactions occur 
between the electropositive and electronegative clouds on aromatic rings, they have energies of 0-
50 kJ/mol.25 There are three possible stacking configurations: edge to face (Figure 4B), face to face 
(Figure 4C) or offset stacking (Figure 4D).26 
  
Page | 10 
 
 
Figure 4 – Illustration of the non-covalent interactions A) dipole-dipole B) π-π edge to face C) π-π face to face D) π-π 
offset. 
The strongest type of non-covalent interaction is the ion-ion interaction, which is comparable 
in strength to the covalent bond, with energies of 100-350 kJ/mol and > 150 kJ/mol respectively. 
Other types of non-covalent interactions are the ion-dipole interactions which occur between a 
charged ion and a dipole on a polar molecule, the cation-π interactions which occur between 
cations and electron rich aromatic ring systems and the anion-π interaction which occurs between 
an anion and an electron deficient ring system (Figure 5).27–29 
 
Figure 5 – Illustrations of non-covalent interactions A) ion-dipole B) cation- π C) anion- π. 
Another non-covalent interaction is the hydrogen bond, the physical properties of the 
hydrogen bond have been studied extensively.30–32 It has an energy range of 4-165 kJ/mol, which 
can be further categorised into weak electrostatic (< 20 kJ/mol), electrostatic (20-60 kJ/mol) or 
covalent interactions (> 60 kJ/mol).33–35 The average bond lengths for electrostatic interactions are 
> 1.5 Å while covalent interactions are between 1.2-1.5 Å.36 Hydrogen bonds can adopt many 
different geometries, such as: linear, bent, bifurcated (accepting and donating), trifurcated and 
three-centred bifurcated (Figure 6).37 Hydrogen bonds are formed through hydrogen bond acceptor 
(HBA) groups, for example, oxygen, nitrogen and sulphur, interacting with electrostatically positive 
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acidic hydrogen atoms acting as hydrogen bond donating (HBD) groups. Although non-covalent 
interactions are weak compared to covalent bonds, the additive effect of many non-covalent 
interactions can stabilise molecular structures. 
 
Figure 6 – Examples of the geometries a hydrogen bond can adopt 1) linear 2) bent 3) accepting bifurcated 4) donating 
bifurcated 5) trifurcated 6) three-centred bifurcated. 
Natural systems contain many examples of supramolecular complex formation, which are vital 
for life. Proteins are an excellent example of supramolecular complexes. Enzymes catalyse all the 
chemical reactions in the body and antibodies bind to foreign particles to help protect it.38,39 These 
molecules are formed of a primary structure, an amino acid chain, which self assembles into a 
secondary structure; α-helixes and β-sheets through hydrogen bonds.40,41 Long amino acid chains 
can self-assemble into many separate secondary structures which folds into a three-dimensional 
structure through other non-covalent interactions, such as hydrophobic interactions, ionic 
interactions and hydrogen bonds, named the tertiary structure.42–44 Furthermore, multiple tertiary 
structures can self-assemble to form a quaternary structure (Figure 7).45 Another inspirational 
biological system is DNA (deoxyribonucleic acid), the structure of DNA was deduced by Francis Crick 
and James Watson in 1953, as two strands of polynucleotides that are complementary and interact 
to form a double helix.46 
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Figure 7 – Illustration of the structures within a protein. A) Primary structure, the amino-acid chain. B) Secondary 
structure, α-helix or β-pleated sheet. C) Tertiary structure, folding of secondary structure into a three-dimensional 
structure. D) Quaternary structure, interactions between two or more tertiary subunits.47 
1.3 DNA 
DNA contains all the genetic information for the construction, function and reproduction of all 
known organisms and viruses.48 DNA is polymer formed of repeating units of nucleotides,49 which 
consists of a nucleobase, sugar and phosphate backbone. A nucleobase bound to a sugar forms a 
nucleoside, then a nucleoside bound to a phosphate group forms a nucleotide (Figure 8).50 Two 
complementary polynucleotide strands interact to form a supra molecule. 
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Figure 8 – Illustration of the structure of a nucleic acid. 
Non-covalent interactions play a vital role in the formation of DNA, both hydrogen bonding and 
π-π interactions are required for the stabilisation of the double helix.51 There are four nucleobases 
in DNA, adenine, cytosine, guanine and thymine. Adenine and guanine are purines, while cytosine 
and thymine are pyrimidines. These types of molecules complement each other and bind through 
hydrogen bonding, forming adenine-thymine (A-T) and cytosine-guanine (C-G) bonds. Adenine 
interacts with thymine through two hydrogen bonds while cytosine interacts with guanine through 
three hydrogen bonds (Figure 9). Due to the additive effects of non-covalent interactions the C-G 
interaction is stronger than the A-T interaction.52 
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Figure 9 – Hydrogen bonding between the complementary base pairs. A) Adenine and thymine. B) Cytosine and 
guanine. 
The π-π interactions occur between the stacked nucleobases, then the stacked nucleobases 
form a dipole, which attracts another nucleobase through van der Waals forces, which is 
propagated throughout the entire polynucleotide. Although these forces are weaker than hydrogen 
bonds individually, recent studies have found that the π-π interactions contribute more to the 
stabilisation of DNA than previously thought.53 DNA replication requires the two strands to 
separate, an enzyme named DNA helicase separates the polynucleotide strands between the 
nucleobases by breaking the hydrogen bonds.54  
Due to the specific self-associating properties of DNA, the Watson-Crick base pairing, it inspired 
a new area of supramolecular chemistry termed ‘supramolecular DNA assembly’.55 By combining 
DNA complementary base pairing with synthetic chemistry, it is possible to design precise assembly 
of molecules. Oligonucleotides have been used as a supramolecular scaffold for the synthesis of 
functional molecules in the nanometre scale. Supramolecular DNA assembly evolved from 2D 
lattices into 3D lattices, starting from a 2D smiley face to lego-like structures which can self-
assemble to form larger 3D structures.56,57 From there, dynamic DNA nanostructures were 
synthesised by Sherman et al,58 where it was demonstrated a DNA footpath could be transversed 
by a DNA bipedal walking device through its oligonucleotide feet.59 While DNA and the interactions 
between it were being studied, chemists were simultaneously researching micelles and 
microemulsions.60 Micelles and microemulsions consist of amphiphiles aggregating through non-
covalent interactions to form extended structures.61 They play an important role in biology and 
have a wide range of consumer applications.  
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1.4 Amphiphiles 
Amphiphiles are molecules that consist of a hydrophilic and hydrophobic component.62 
Depending on the nature of the hydrophilic group, amphiphiles can be categorised as neutral, 
anionic, cationic or zwitterionic.63 Neutral amphiphiles do not carry a charge, their solubility is 
dependent on the functional groups and how easily they deprotonate (Figure 10A). Anionic 
amphiphiles carry a negative charge, common head groups are carboxylates, sulphates, sulfonates 
and phosphates (Figure 10B).64 Cationic amphiphiles carry a positively charged head group, amines 
or ammonium ions are common examples (Figure 10C).65 While a zwitterionic amphiphile carries 
both a positive and negative charge in the head group (Figure 10D).66 The hydrophobic component 
usually consists of a hydrocarbon chain, however, there are exceptions such as aromatic rings and 
trifluoromethyl functional groups.67,68 
 
Figure 10 – Examples of amphiphiles: A) Neutral; B) Anionic; C) Cationic; D) Zwitterionic. 
Amphiphiles can aggregate to form different structures, this is achieved by maximising the 
preferred interactions while minimising the non-preferred interactions. Which leads to the 
following structures: micelles, reverse micelles, lipid bilayers or vesicles. Micelle can form when the 
amphiphiles are in a polar solution (Figure 11A), whereas in a non-polar solution, the amphiphiles 
will form a reverse micelle (Figure 11B).69 The number of hydrophobic moieties of the amphiphile 
itself can affect the result of the aggregate formation. For example, Phospholipids with a single 
hydrocarbon chain can aggregate into micelles, while amphiphiles with multiple hydrocarbon 
chains form bilayer structures as the chains are too large to fit inside a micelle (Figure 11 C, D).70 
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These structures play an important role in biological systems. The lipid bilayers compartmentalise 
different cells to increase efficiency, while micelles and vesicles transport water insoluble products 
in and out of the cells.71 
 
Figure 11 – Examples of amphiphile aggregation. A) Single chain amphiphile in a polar solvent. B) Single chain amphiphile 
in a non-polar solvent. C) Double chain amphiphile forming a lipid bilayer. D) Double chain amphiphile forming a vesicle. 
Peptides are proteins that are produced in all living organisms and have shown 
pharmacological activity against microbes. The antimicrobial peptides are oligopeptides and most 
are charged amphiphiles that display minimal toxicity to mammalian cells.72–74 In contrast to other 
types antimicrobials, which target DNA or enzymes on the membrane, antimicrobial peptides 
associate with cell membranes of the microbes, this discovery has consequently led to the 
development of new amphiphilic drugs. Examples include: tranquilizers,75 antihistamines,76 
antibiotics,77 antidepressants,78,79 β-blockers and more.80 Over the last decade amphiphiles have 
been developed into supra-amphiphiles,81 they interact through non-covalent interactions.82 A 
study conducted by Wang et al., stated there are two main ways to create a supra-amphiphile; 
firstly, through the combination of the hydrophobic and hydrophilic components using non-
covalent interactions or dynamic covalent bonds to create the amphiphile.83 The other method was 
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to modify a molecule with non-covalent interactions, changing the physical properties of the 
molecule, such as the amphiphilicity.84  
Meanwhile, low molecular weight amphiphiles have been found to self-associate through 
hydrogen bonds,85 especially those with urea functional groups.86 Combining these concepts, 
Faustino et al. developed a series of anionic urea based salts derived from sulphur containing amino 
acids (Figure 12A, B).87 The studies show hydrogen bonding occurs at the urea moiety, however it 
did not affect micelle formation. The amphiphile also showed no antimicrobial activity which was 
presumed to be due to the short alkyl chains.  
Following this, Pittelkow et al. synthesised aromatic, anionic-urea salts derived from 
sweeteners (Figure 12C).88–90 However, the main focus of the research was on the complexation of 
dendrimers, thus the self-association properties of these low molecular anionic-urea compounds 
were not analysed. Hiscock et al. modified the sulfonate-urea salts and began to look at the self-
association properties of the compounds and found some of these amphiphilic salts showed signs 
of antimicrobial activity (Figure 12D).91 
 
Figure 12 – Illustration of the evolution of anionic urea amphiphile A) anionic monomeric urea amino acid B) anionic 
dimeric urea amino acid C) anionic aromatic urea D) modified anionic aromatic urea. 
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The amphiphile consists of an anionic hydrophilic HBA group and a urea groups which can 
adopt a minimum of four different binding modes. These binding modes cannot exist at the same 
time making the system ‘frustrated’. The amphiphile can self-assemble through the urea-urea or 
urea-anion through hydrogen bonding. Binding through the urea-urea can form a dimer or tape 
structure, whereas binding through the urea-anion the compound forms either a syn-stacking or 
anti-stacking structure (Figure 13). The research concluded the binding mode was dependant on 
the molecular structure of the amphiphile and the solvent system the aggregate was assembled in. 
 
Figure 13 – Possible self-associated hydrogen bonded modes of the modified anionic urea compounds.  
Subsequently, Hiscock et al. expanded the collection of amphiphiles while keeping the general 
structure.92 The functional groups on the hydrophobic aromatic ring were altered, electron 
withdrawing groups such as an amide or more electron donating group such as a nitro group were 
affixed. The urea moiety was swapped to a thiourea moiety and the cation was exchanged. The self-
association properties of these compounds were analysed in all three states: solid state, gas phase 
and solution state.93 
The research concluded that compounds containing urea-anionic moieties with a weakly 
coordinating counter cation forms urea-anion complex. These compounds formed dimeric species 
in the gas phase, additionally, within the solution state, these compounds also tend to form dimeric 
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species within DMSO. Whereas in H2O: EtOH 19:1 solution the compounds formed aggregates with 
a size of 91-460 nm, 3 of the compounds showed signs of antimicrobial activity when tested against 
Staphylococcus aureus (S.aureus) and Escherichia coli (E.coli).92,94 
The next step was to investigate the mode of action of the compounds and visualise them using 
microscopy, intrinsically fluorescent compounds were synthesised.93 The compounds aggregate 
and form micellular-like structures (Figure 14A), which coats the surface of the S.aureus cell (Figure 
14B, C). Finally, the compound penetrates the membrane, internalises within the cell and appears 
to associate with the nucleoid (Figure 14D, E).95 
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Figure 14 – A) Overlaid fluorescence and transmitted light microscopy image of green micellular aggregates binding to 
the bacterial membrane of S.aureus. B) Fluorescence confocal microscopy image of the aggregates (white) coating the 
bacterial membrane of S.aureus. C) Overlaid fluorescence and transmitted light microscopy image of the aggregates (pink) 
coating the bacterial membrane of S.aureus. D) Overlaid fluorescence and transmitted light microscopy image of the 
aggregates (pink) interacting with the nucleoid of S.aureus. E) Fluorescence confocal microscopy image of the aggregates 
(white) interacting with the nucleoid of S.aureus. Attributed to Jennifer Hiscock, Dan Mulvihil and Laura Blackholly. 
Due to the compounds interaction with the nucleoid, Hiscock et al. synthesised a DNA inspired 
molecule (Thymine) derived from the previous compounds;96 the study reports the molecule self-
associates to form dimers in DMSO and the DOSY NMR studies report the solvation sphere diameter 
at 1.6-1.8 nm depending on the concentration. The crystal structure of the molecule shows that it 
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dimerises then the dimers interact to form a tetramer. The tetramers then interact again to form a 
pseudo porous extended structure. The paper shows the tetramer forms through the amide NH 
leaving the thymine moiety free to interact (Figure 15). 
 
Figure 15 – Illustration of the dimer formation of the thymine inspired molecule. 
As the thymine moiety is free to interact and is part of a complementary base pair, an adenine 
inspired molecule can be synthesised to attempt to form a preorganised extended aggregate 
through DNA base pairing. 
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1.5 Project Aims  
The aims of this project are to synthesise a complementary molecule to the thymine inspired 
amphiphile.96 Hence, an adenine inspired amphiphile will be synthesised, characterised and the 
self-association and complex formation properties will be explored within the solid state, gas phase 
and solution state using single crystal X-ray diffraction, negative electrospray ionisation mass 
spectrometry (ESI-MS), NMR spectrometry, dynamic light scattering (DLS), zeta potential, 
tensiometry and low level computational modelling. Compounds 1 and 2 will be synthesised as the 
precursor to compounds 3-5. As compounds 3-5 are complex molecules, compounds 6-10 will be 
synthesised to break down the complex interactions between the DNA inspired molecules (Figure 
16). Previous amphiphiles have shown antimicrobial properties,94 therefore, compounds 3-5 will be 
also be tested for antimicrobial properties. It has been shown that the amphiphiles interact with 
the nucleoid, it is hypothesised that the DNA inspired amphiphiles will interact with any single 
stranded DNA and further increase efficacy. The amphiphiles will be tested against S.aureus and 
E.coli. 
 
Figure 16 – Structures of compounds 1-10. 
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2. Results and discussion 
2.1 Synthesis 
The synthesis of compounds 1 and 2 has been previously published,91,92 they are required for 
the synthesis of compounds 3-5 (Figure 17). Compound 3 was also previously published and 
synthesised accordingly, however; it could not be purified according to the method. Compound 4 
was synthesised through an amide couple reaction of compound 2, 2-nitroisonicotinic acid and 1-
Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) with a final yield of 51 %. Finally, compound 5 
was synthesised through a reduction of compound 4 using hydrazine hydrate and palladium on 
carbon (Pd/C) with a yield of 84 %.  
 
Figure 17 – Synthesis scheme for compounds 1-5.  
Compound 3 was synthesised with each attempt; however, many problems arose. Initially, 
there was still starting material in the crude product (Figure 18A), this was due to the reactant, 
N,N’-Carbonyldiimidazole (CDI) decomposing to form imidazole. The amount of CDI was increased 
to drive the reaction to completion; however, this caused the crude product to contain excess 
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imidazole, which was challenging to remove (Figure 18B). Hence, other coupling agents, such as 
N,N′- Dicyclohexylcarbodiimide (DCC) and 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) 
were used in an attempt to synthesis compound 3. DCC successfully yielded Compound 3, but 
contained excess TBA (Figure 18C). Separations, precipitations and columns were used to remove 
the excess TBA, however, all methods removed all the TBA instead (Figure 18D). After these 
attempts, a literature based method was found to use N-Hydroxysuccinimide (HOSu) to stabilize 
the thymine analogue from the contributing structures before the coupling process, this method 
was applied to the synthesis process and the yield increased to 54% (Figure 18E). 
 
Figure 18 - A) Overlaid 1H NMR of Compound 2 and compound 3 using the previously published method. B) 1H NMR of 
Compound 3 synthesised with additional CDI. C) 1H NMR of Compound 3 synthesised using DCC showing a higher ratio 
of TBA. D) 1H NMR of Compound 3 with TBA removed. E) 1H NMR of compound 3 synthesised using the final method. 
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2.2 Self-association in the solid state 
2.2.1 Single-crystal X-Ray diffraction 
A single crystal is a material in which the crystal lattice of the entire sample is continuous, 
single crystals can be formed from almost all materials. As the crystals have a repeating pattern, 
Max von Laue suggested the use of crystals as a grating for the diffraction of X-rays.97 Due to the 
non-destructive nature of the technique, it is used to obtain a three-dimensional structure of the 
material and it can observe both covalent and non-covalent interactions in the solid state.98 Crystals 
of compounds 4, 5, 7 and 10 were obtained through slow evaporation of a H2O: MeOH 19:1 
solution, while crystal structures of compounds 1-3 were previously published,92 compounds 1 and 
2 forms dimers through urea-anion interactions, while compound 3 forms a tetramer through urea 
oxygen-amide NH interactions. A crystal structure of the 1:1 mixture of compounds 3 and 5 was not 
obtained. Many solvent systems were attempted; however, a crystal was not produced. 
Crystallography data was obtained and refined by Dr. Jennifer Hiscock. 
2.2.1.1 Results and discussion 
The crystal structure of compound 4 exhibits a dimerization between the urea-anion through 
the formation of four hydrogen bonds, like previously published compounds (Figure 19).92 However, 
it also shows a water-bridged urea-pyridine and an amide-sulfonate hydrogen bond extending the 
aggregate species. 
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Figure 19 – Single crystal X-ray structure of compound 4, exhibiting hydrogen bonded extended structures. TBA counter 
cation has been omitted for clarity. 
Compound 5 also forms the dimeric species between the urea-anion with four hydrogen bonds 
(Figure 20). End-end interactions are also seen in the crystal structure through the HBD nitrogen 
and HBA amino functional group on the aminopyridine forming two hydrogen bonds. Sulfonate-
aminopyridine interactions are also seen within the crystal structure and are either directly bonded 
or water-bridged. 
 
Figure 20 – Single crystal X-ray structure of compound 5, exhibiting hydrogen bonded extended structures. TBA counter 
cation has been omitted for clarity. 
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Compound 7 forms a hydrogen bond between the amide-amide moiety, forming a syn-stacking 
structure (Figure 21).  
 
Figure 21 – Single crystal X-ray structure of compound 7, exhibiting hydrogen bonded syn-stacking through an amide-
amide binding mode. 
Compound 10 forms a dimer through two hydrogen bonds between the amide on the ring and 
the oxygen in between two nitrogen atoms (Figure 22). It was hypothesised that it interacts there 
due to the inductive effect of electron donating nitrogen causing the oxygen to be a stronger HBD. 
 
Figure 22 – Single crystal X-ray structure of compound 10, exhibiting a hydrogen bonded dimer.  
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To conclude, all crystal structures show the formation of a dimeric species and the sulfonate-
urea amphiphiles show the same interaction at the sulfonate-urea as with previously published 
amphiphiles.99  
2.3 Self-association in the gas phase 
2.3.1 Electrospray ionisation mass spectrometry 
ESI-MS has become an irreplaceable tool in science, it provides qualitative information about 
the analytes and it can preserve weak non-covalent bonds in the gas phase.100 However, molecules 
must be an ionic species or be converted into an ionic species to use this technique, this is achieved 
through injecting the sample into an ionisation source.101 Compounds 3-8 were analysed using 
negative ESI-MS to determine whether low complex formation could be seen in the gas phase. 
2.3.1.1 Results and discussion 
The data obtained from the ESI-MS show that compounds 3-8 behave the same as the previous 
compounds, existing as both the monomers and dimers in the gas phase. Compounds 3-5 are salts, 
therefore shows the monomeric state [M]- and dimeric state [M + M + H+]- (Table 1). The dimer is 
not limited to the hydrogen ion, other ions such as sodium and potassium can be seen,94 however, 
were not looked at here. Sample preparation was completed to ensure optimization, resulting in a 
very low concentration of the analysed sample (1 mg in 1 mL, diluted further by a factor of one 
hundred giving the concentrations at ≈ 1.6 x 10- 6 mol). 
Table 1 – High Resolution mass spectrometry theoretical and experimentally derived values for compounds 3-5. 
Compound 
m/z [M]- m/z [M + M + H+]- m/z [M + M + M + 2H+]- 
Theoretical Actual Theoretical Actual Theoretical Actual 
3a 410.0771 410.0755 821.1612 821.1591 1232.2453 N/A 
4 394.0458 394.0440 789.0986 789.0951 1184.1514 N/A 
5 364.0716 364.0702 729.1502 729.1471 1094.2288 1094.2227 
a – Previously published data.96 
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The protonated dimeric species for compounds 3-5 were observed. Using compound 4 as an 
example (Figure 23). The monomeric [M]- m/z peak is observed at 364.0702 and the protonated 
dimeric species [M + M + H+]- is observed at (2 x 410.0755) + 1.007 = 729.1471, this indicates that a 
dimerised species is present in the gaseous phase. This trend is apparent for compounds 3 and 5, 
moreover, compound 5 also indicates that a trimeric species [M + M + M + 2H+]- is present at (3 x 
364.0702) + (2 x 1.007) = 1094.2227. The appearance of the trimeric species in the gas phase has 
not yet been seen in any previously published compounds, further investigation of the trimer will 
be required to determine the reason for its presence. 
 
Figure 23 – Electrospray mass spectrometry spectrum of compound 5, showing both the monomeric, dimeric and trimeric 
species (A), monomeric species (B) and protonated species (C). 
Alternatively, compounds 6-8 are neutral species, therefore requires ionisation to show the 
monomeric state [M - H+]- (Table 2).  
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Table 2 – High Resolution mass spectrometry theoretical and experimentally derived values for compounds 6-8. 
Compound 
m/z [M – H+]- m/z [M + M – H+]- 
Theoretical Actual Theoretical Actual 
6 303.0738 303.0863 607.1546 607.1776 
7 310.0448 310.0433 621.0966 621.0916 
8 280.0706 280.0820 561.1482 561.1680 
The deprotonated dimeric species were observed for compounds 6-8. Using compound 6 as an 
example (Figure 24, 25). The monomeric [M - H+]- m/z peak is observed at 304.2620 – 1.007 = 
303.0863 and the deprotonated dimeric [M + M - H+]- m/z peak is observed at (2 x 304.2620) – 
1.007 = 607.1776. This trend is also apparent for compounds 7 and 8.  
 
Figure 24 – Electrospray mass spectrometry spectrum of compound 6 showing the monomeric species. 
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Figure 25 – Electrospray mass spectrometry spectrum of compound 6 showing the dimeric species. 
The ESI-MS data reveals that the non-covalent bonds of compounds 3-8 do not dissociate under 
these conditions, indicating the strength of the interactions of these low complex formations are 
quite strong. The strength of the interactions cannot be determined within the gas phase; 
therefore, the self-association properties of the compounds will be explored in the solution state. 
All ESI-MS for compounds 3-8 can be found in the appendix (Figures 89-100). 
2.4  Association in the solution state 
The solid state and gas phase complex formations occur in the absence of solvent-solute 
interactions. This allows us to observe the interactions between the compounds, however, in the 
solution state, solvent-solute interactions can alter the complex formation when self-associating. 
The solvent molecules can act as HBA or HBD which plays a role in the self-association of molecules. 
For example, water is a polar protic solvent, which interacts through the proton when hydrogen 
bonding, acting as a HBA. Whereas DMSO is a polar aprotic solvent, it interacts with solutes through 
the oxygen atom acting as a HBD.102 Previous studies by Hiscock et al. conclude that this class of 
novel amphiphiles tend to form dimers in DMSO, while in an aqueous H2O: EtOH 19:1 solution they 
form aggregates with an approximate size of 100-500 nm.92 Compounds 3-5 consists of the same 
hydrophilic sulfonate anion and urea moieties; these compounds will be analysed with the same 
techniques to investigate their self-association properties. 
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2.4.1 1H NMR quantification studies 
Quantitative 1H NMR (qNMR) is a technique which compares the compound with an internal 
standard to calculate the proportion of molecules in solution. This technique utilises an inherent 
property of NMR; the magnitude of each NMR signal is proportional to the number of nuclei 
responsible for the peak.103 Therefore, using a known standard and a known concentration of the 
compound, it is possible to calculate the percentage of molecules in the solvent. If the percentage 
is lower than 100% in the solvent, they are classified as being ‘NMR silent’ as it is outside the 
limitations of this technique. The limitations to solution state NMR spectroscopy are as followed, 
sensitivity, natural abundance of the isotope and solubility of the molecule. It is possible to restrict 
the limitations of sensitivity and natural abundance of the isotope by using a concentrated sample 
and a nucleus with a high natural abundance, in this case, 1H NMR.104 Therefore, if the compound 
is ‘NMR silent’ it will be due to the compound self-associating into an aggregate that adopts solid-
like characteristics and can no longer be seen by solution state NMR. 
Herein, compounds 3-5 and a 1:1 mixture of compounds 3 and 5 will be compared using 
previously used solvents, DMSO-d6 and water. The DMSO will be spiked with 1% DCM as the internal 
standard due to the peak appearing at 5.76 ppm, which appears away from the compound signals. 
The D2O will be spiked with 5% EtOH as the internal standard due to the peak appearing at 3.65 
ppm, away from the aromatic signals and can, therefore, be referenced. 
2.4.1.1 Results and discussion 
The data obtained from the qNMR studies show that there is no loss of compound in DMSO for 
compounds 4 and 5, whereas there is a loss of compound 3 and the mixture (Table 3). Compound 
3 shows no loss in the H2O: EtOH solution, while compounds 4,5 and the mixture shows a loss in 
the H2O: EtOH solution. 
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Table 3: Overview of the calculated % loss of compound at a total concentration of 111.12 mM in DMSO-d6 and a total 
concentration of 6.00 mM in H2O: EtOH 19:1 solution for compounds 3-5 and the 1:1 mixture of compounds 3 and 5. 
Compound 
% Loss 
DMSO-d6 w/ 1% DCM D2O w/ 5% EtOH 
3* 6 0 
4 0 29 
5 0 32 
3 and 5* 7 58 
* = repeated three times. 
The results show a small percentage of compound 3 and the mixture form aggregates with 
solid-like characteristic. This is unusual as most previously published compounds show no loss in 
DMSO-d6, similar to compounds 4 and 5. Therefore, this experiment was repeated three times to 
check the validity of the results, showing an average loss of 6 % and 7 % of compound 5 and the 1:1 
mixture, respectively. On the other hand, in D2O compound 3 shows no loss, while compounds 4, 5 
and the mixture shows a loss of 29, 32 and 58 %, respectively. Which indicates approximately a 
third of compounds 4 and 5 forms extended aggregates which cannot be seen by this technique 
and a combination of compounds 3 and 5 causes more molecules to be aggregated in D2O, 
indicating a greater interaction when the compounds are combined. Using compound 3 in DMSO 
as an example, the DCM peak is calculated to be 2.87. The CH2 peak at 3.65 ppm should integrate 
to be 2, however, it only shows 1.88 (Figure 26). Therefore, it is possible to see 94 % of the 
compound, while 6 % is lost to solid-like characteristics. Compound 3 is different from the 
previously published compounds, the results for the qNMR the opposite to what was found. It is 
hypothesised that as the functional group on compound 3 is not aromatic, it is less hydrophobic 
than compounds 4 and 5, hence, is more soluble in the H2O: EtOH solution. Further research will be 
carried out to find the cause of this anomaly. All qNMR spectra can be found in the appendix 
(Figures 101-108). 
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Figure 26 – 1H NMR spectrum (d1 = 60 s) of compound 3 (0.0364 g, 111.12 mM) and DCM (5 µl, 0.08 mM) in DMSO-d6. 6% 
loss of compound observed upon comparative signal integration. 
2.4.2 1H NMR DOSY studies 
1H NMR DOSY studies is used to calculate the hydrodynamic radius of the complex in solution. 
The 1H NMR DOSY experiment reports the diffusion coefficients for the individual resonances in a 
1H NMR spectrum, then using the Stokes-Einstein equation (Equation 1), the solvation sphere 
diameter can be calculated. 
Equation 1 – The Stokes-Einstein equation used to calculate the hydrodynamic diameter from the diffusion coefficient. 
 
To calculate the solvation sphere diameter of a compound, the calculation assumes that the 
particle is spherical, however, in practice the particle shapes are not spherical (Figure 27). 
Therefore, the size of particles obtained from this experiment will be treated as an estimate. 
11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
1.882.87
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Additionally, the hydrodynamic diameter can only be determined if the compounds are fully 
observable in the solution with this technique. Herein, the 1H NMR DOSY will be carried out in 
DMSO-d6, compound 3 and the 1:1 mixture will be done in the future as due to synthetic troubles 
leading to time constraints. 
 
Figure 27 – Examples of non-spherical particles and how the hydrodynamic diameter would be calculated. 
2.4.2.1 Results and discussion 
The 1H NMR DOSY results calculate that compounds 4 and 5 have a diameter of 1.78 and 1.94 
nm, respectively (Table 4). Which represents low complex formation, such as monomers, dimers or 
trimers.  
Table 4 – Calculated hydrodynamic radius of compounds 4 and 5 (nm) in DMSO-d6 (111.12 mM). 
Compound 
Hydrodynamic diameter (nm) 
Anion Cation 
4 1.78 1.28 
5 1.94 1.37 
The results calculate the cation and anion have different diffusion constants, hence the 
compound and its counter cation, TBA, does not coordinate strongly in DMSO-d6. The 1H NMR DOSY 
spectra and the table of diffusion coefficients can be found below (Figure 28, 29). 
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Figure 28 – 1H DOSY NMR of compound 4 (111.12 mM) in DMSO-d6 conducted at 298.15 K. Anionic component 
highlighted in blue, TBA counter cation highlighted in red. Including the table representing the values for the diffusion 
constant for each peak used to calculate the hydrodynamic diameter (dH). Peaks 1-9 correspond to the anionic 
component of compound 4, while peaks 10-13 correspond to the cationic component of compound 4. 
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Figure 29 – 1H DOSY NMR of compound 5 (111.12 mM) in DMSO-d6 conducted at 298.15 K. Anionic component 
highlighted in blue, TBA counter cation highlighted in red. Including the table representing the values for the diffusion 
constant for each peak used to calculate the hydrodynamic diameter (dH). Peaks 1-10 correspond to the anionic 
component of compound 5, while peaks 11-14 correspond to the cationic component of compound 5. 
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 2.4.3 1H NMR self-association studies 
A series of 1H NMR dilution studies were performed to explore the strength of the molecular 
interactions. The dilution studies were conducted for compounds 4 and 5 in DMSO-d6 with 0.5 % 
H2O at a constant temperature of 298.15 K. This solvent system allowed the binding mechanism of 
the HBD urea NH groups to be studied. The data was processed under the assumption of the 
compounds forming low complex species from the DOSY results, the data obtained from 1H NMR 
dilution studies was used to calculate self-association constants using a program called Bindfit 
v0.5,105 showing the strength of the self-association within the molecule. The data was fitted to 
both dimerization/ equal K (EK) and cooperative equal K (CoEK) models. Both of these models 
assume one component, one-dimensional homogenous aggregation.106 The EK model assumes all 
self-association constants are identical (Equation 2A), whereas, the CoEK model assumes the first 
association event has a different energy compared to all of the subsequent events (Equation 2B).107 
If ρ < 1 there is positive cooperativity, if ρ > 1 then there is negative cooperativity and if ρ = 1 then 
it is non-cooperative. 
Equation 2 – One component general linear aggregation system and the EK (A) and CoEK binding model (B). 
 
2.4.3.1 Results and discussion 
The results of the self-association studies for compound 4 show that for the urea NH’s the 
chemical shift increases downfield as the concentration increases (Figure 30). This indicates the 
protons becomes more deshielded, suggesting the formation of a self-associating hydrogen bonded 
molecule at the urea NH. The amide NH (grey) has a negative change in chemical shift becoming 
more shielded, showing a hydrogen bond breaking. There are several hypothesises for this result; 
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inductive effects could cause the amide NH to be more shielded or it could already be a complexed 
molecule and the upfield change in chemical shift shows the complex breaking at the amide. 
 
Figure 30 – Graph illustrating the 1H NMR down-field change in chemical shift of NH resonances with increasing 
concentration of compound 4 in DMSO- d6 - 0.5 % H2O (298.15 K). 
Compound 5 shows a similar trend to compound 4 where the urea NH’s show a downfield 
change in chemical shift (Figure 31), while the amide NH also shows an upfield shift (grey). There is 
no change in chemical shift for the amine NH2 which shows there are no interactions at that point 
(yellow), which leaves it free to interact. 
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Figure 31 – Graph illustrating the 1H NMR down-field change in chemical shift of NH resonances with increasing 
concentration of compound 5 in DMSO- d6 - 0.5 % H2O (298.15 K). 
Both compounds were successfully fitted to both the dimerisation EK and CoEK model. 
Comparatively, the CoEK model shows a self-association constant approximately four times 
stronger than the EK model, however, considering the associated errors calculated for both models, 
the data supports the EK model. It is possible to conclude that the compounds dimerise with equal 
energies and the interacts are weak. 
Table 5 – Self-association constants (M-1) calculated for compounds 4 and 5 in a DMSO-d6 – 0.5% H2O solution at 298 K. 
These constants were obtained from the fitting of 1H NMR dilution data and refined to EK and CoEK models using 
Bindfit v0.5.105 The links for the Bindfit data are be provided within the appendix. 
Compound 
EK Model (M-1) CoEK Model (M-1) 
Ke Kdim Ke Kdim ρ 
4 1.41 (± 1.5 %) 0.71 (± 0.7 %) 10.91 (± 3.4 %) 5.45 (± 1.7 %) 0.30 (± 10.0 %) 
5 1.78 (± 0.6 %) 0.89 (± 0.3 %) 8.32 (± 3.1 %) 4.16 (± 1.6 %)  0.50 (± 5.2 %) 
1H NMR dilution studies will be performed on compounds 7 and 8 in the future to model the 
interactions at the nitro/aminopyridine.  
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2.4.4 1H NMR titration studies 
A series of 1H NMR titration studies were carried out for compounds 4, 5, 7-9 as hosts molecules 
with compounds 10 and TBA HSO4- as guest molecules to mimic the thymine functional group and 
the sulfonate anion, respectively. This would allow us to calculate the strength of the interaction 
between the molecules. The titration results for compound 9 and TBA HSO4- are previously 
published,96 it models the urea-sulfonate interaction and it is shown to interact with a weak 
association constant of 27 M-1. Association constants were calculated using Bindfit v0.5,105 refining 
it to three binding isotherms, these models assume one component, one-dimensional homogenous 
aggregation. Each NH resonance was separately refined to distinguish whether the interaction 
formed on a 1:1, 1:2 and 2:1 relationship. These studies were performed in collaboration with Milan 
Dimitrovski. 
2.4.4.1 Results and discussion 
The titration results of compound 4 with compound 10 show no correlation between the two 
compounds (Figure 32). The change in chemical shift between the compounds is negligible (< 0.01 
ppm), concluding that compound 4 does not interact with compound 10. 
 
Figure 32 – A graph showing the downfield 1H NMR change in chemical shift for each NH in compound 4 (host) with 
increasing the concentration of compound 10 (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
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Titration results of compound 4 with TBA HSO4- show an interaction between the molecules 
(Figure 33). However, it is not possible to fit these data to a binding model as multiple interactions 
are occurring within this system and is therefore no longer a one component system. 
 
Figure 33 – A graph showing the downfield 1H NMR change in chemical shift for each NH in compound 4 (host) with 
increasing the concentration of TBA HSO4- (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
The titration results for compound 5 with compound 10 show no correlation, as the change in 
chemical shift is negligible (Figure 34). The two compounds were theorised to interact; however, it 
is hypothesised that the compound 5 interacts with the solvent, preventing the interaction between 
the compounds. 
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Figure 34 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 5 (host) with 
increasing the concentration of compound 10 (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
The titration results of compound 5 with TBA HSO4- show correlation with the urea NH and the 
amino group (Figure 35). The results correspond to the crystal structure showing an interaction 
between the sulfonate-urea (Figure 20). The graph also shows an interaction between the amino 
functional group and the sulfonate, which is also seen in the crystal structure. These data were 
unable to be fitted to the Bindfit model as multiple interactions are occurring in this system. 
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Figure 35 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 5 (host) with 
increasing the concentration of TBA HSO4- (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
The titration results for compound 7 with compound 10 shows that there is no interaction 
between them as the change in chemical shift is negligible (< 0.01 ppm) (Figure 36). Using the results 
from this experiment and the titration between compound 4 and 10, there is no complex formation 
between compounds 7 and 10, this was expected as nitropyridine is not an analogue of adenine. 
 
Figure 36 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 7 (host) with 
increasing the concentration of compound 10 (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
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The titration results for compound 7 with TBA HSO4- show a weak association between them 
(Figure 37), it can be concluded that the compounds interact with a 1:1 ratio due to the numbers 
calculated for the 1:2 and 2:1 host: guest ratio either being too large or negative. However, the 
interaction between the sulfonate and the amide is weak. 
 
Figure 37 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 7 (host) with 
increasing the concentration of TBA+ HSO4- (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
Table 6 – Association constants (M-1) calculated for each NH in compound 7 (host) titrated against TBA+ HSO4- (guest) in 
a DMSO-d6 – 0.5% H2O solution (298 K). The links for the Bindfit data is provided within the appendix. 
Host: Guest 1: 1 1: 2 2: 1 
NH K K11 K12 K11 K21 
Circle 
3.35 (± 1.1 %) 
436846684486 
(± 8309238 %) 
3.49 (± 1.8 %) 
-48.36  
(± -9.0 %) 
-24.69 
(± - 8.1 %) 
The titration results for compound 8 with compound 10 show a negative change in chemical 
shift, which here represents an upfield shift (Figure 38). However, these data could not be fitted to 
the Bindfit models as self-association is suspected, therefore, has multiple interactions occurring in 
this system. The dilution study of this compound is will be carried out in the future to figure out this 
complex system. 
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Figure 38 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 8 (host) with 
increasing the concentration of compound 10 (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
The titration results for compounds 8 and TBA+ HSO4- shows an interaction between the 
aminopyridine and the sulfonate (Figure 39). The initial upfield change in chemical shift suggests a 
hydrogen bond breaking, which is hypothesised to be the interruption of the self-associated 
species. Then the downfield change in chemical shift is hypothesised to be a complex formation 
between compounds 8 and 10 as the crystal structure of compound 5 shows an interaction between 
the aminopyridine-sulfonate (Figure 20). 
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Figure 39 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 8 (host) with 
increasing the concentration of TBA+ HSO4- (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
The titration results for compound 9 and compound 10 shows that there is an interaction 
between them (Figure 40), there is a weak 1:1 association constant of 26 M-1 and 17 M-1 between 
the two NHs. The 1:2 and 2:1 binding models were not accepted as the errors are too large or the 
association constant is negative.  
 
Figure 40 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 9 (host) with 
increasing the concentration of compound 10 (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
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Table 7  – Association constants (M-1) calculated for each NH in compound 9 (host) titrated against compound  10 -
(guest) in a DMSO-d6 – 0.5% H2O solution (298 K). The links for the Bindfit data is provided within the appendix. 
Host: Guest 1: 1 1: 2 2: 1 
NH K K11 K12 K11 K21 
Circle 
25.92 (± 5.7 %) 
2010437381651813 
(± 169434405 %) 
20.46 (± 9.7 %) 
56.18  
(± 97.5 %) 
639.76  
(± 112.9 %) 
Triangle 
17.33 (± 4.8 %) 38.31 (± 9.3 %) 
-5.25  
(± -24.1 %) 
0.00881 
(± 104.1 %) 
5400616 
(± 115.3 %) 
 
From the titration results, we can conclude that thymine does not interact with the 
nitropyridine amide functional group. However, the sulfonate shows interaction with the amide, 
hence, it is possible to form amide-sulfonate interactions, this is observed in the solid state (Figure 
19). As hypothesised, the thymine shows an interaction with the aminopyridine, but the 
aminopyridine also shows an interaction with the sulfonate and the thymine interacts with the 
urea. Therefore, it is hypothesised that with compound 5, there are competitive interactions 
between the sulfonate-aminopyridine, thymine-urea and thymine-aminopyridine weakening the 
thymine-aminopyridine interaction. 
2.4.5 Dynamic light scattering (DLS) and zeta potential 
DLS is a non-destructive technique used to determine the state of motion of particles and the 
spherical size of the particles which have been dissolved in a solvent system.108 Moreover, the lower 
limit of particle size in DLS is approximately 1 nm,109 therefore, low ordered complex species will be 
visible but the data will not be reliable. From the qNMR studies, the data shows over a quarter of 
the molecules in compounds 4, 5 and the mixture of compounds 3 and 5 forms an aggregate with 
solid-like characteristics in H2O: EtOH 19:1 solution, compound 3 was also tested in this study to 
compare with the mixture. It is assumed they form large aggregates that precipitate out of solution, 
DLS will be used to measure the size of these aggregates. DLS studies were not conducted for 
compound 3 as it did not show any loss of compound from the qNMR studies. These studies were 
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conducted at 3.00 mM due to solubility issues, then diluted to 0.30 mM to check whether the 
aggregates still form in a diluted sample. The sample was annealed to allow the aggregate to obtain 
a thermodynamic minimum. Zeta potential was also measured in the same solution to determine 
the stability of the aggregates formed in solution at 3.00 mM. Literature states that a zeta potential 
in between -30 mV and 30 mV is considered unstable.110  
2.4.5.1 Results and discussion 
The results show that compounds 4, 5 and the 1:1 mixture forms stable extended aggregates 
(> 50 nm and zeta potential < -30 mV) in a H2O: EtOH 19:1 solution (Table 11). The aggregates 
formed from compound 4 are larger than 5 and the mixture of compounds 3 and 5, however, the 
polydispersity index (PDI) increases from 26 % to 96 % which signifies it goes from a uniform 
distribution to a non-uniform distribution. Therefore, it is possible to conclude that this compound 
is relatively unstable in comparison to compound 5 and the mixture. This hypothesis is supported 
by the zeta potential, although it is considered stable at < -30 mV it is at the boundary of what is 
considered stable. Hence, it can be concluded that as the concentration decreases, the stability of 
the compound decreases too. Compound 5 forms aggregates with a size of 189 nm which decreases 
when the concentration decreases. However, as the concentration decreases, the PDI of the 
compound also decreases from 23 % to 14 %, which shows the aggregates become more uniform. 
The mixture of compounds 3 and 5 forms the smallest aggregates in comparison, with a size of 94 
nm down to 88 nm with decreasing concentration. As the PDI change is negligible as concentration 
decrease, it indicates that the aggregates remain stable. The addition of compound 3 to compound 
5 shows that it decreases the stability and size of the aggregates. This could be due to compound 3 
being more hydrophilic hence decreasing the stability of compound 5 in a H2O solution. Compound 
3 appears to form extended aggregates in a H2O: EtOH 19:1 solution, however, the zeta potential 
shows that the aggregates that are formed are unstable within this solution. This is hypothesised 
to be due to the hydrophilic properties of the compound.  
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Table 8 – Average intensity particle size distribution for compounds 3-5 and a 1:1 mixture of compounds 3 and 5 
calculated from 10 DLS runs at a total concentration of 3.00 mM and 0.3 mM. Zeta potential for compounds 3-5 and a 
1:1 mixture of compounds 3 and 5, calculated from 10 runs at a total concentration of 3.00 mM. Samples were 
prepared in series, with an aliquot of the most concentrated solution undergoing serial dilution and measured after 
heating to 40 ⁰C and cooling to 25 ⁰C. Error = standard error of the mean. 
Compound 
Peak maxima (nm) PDI (%) Zeta potential 
(mV) 3 mM 0.3 mM 3 mM 0.3 mM 
3 147.23 (± 7.4) 126.23 (± 2.85) 25.02 (± 0.7) 21.79 (± 0.3) -14.40 
4 230.97 (± 12.8) 222.45 (± 9.7) 26.13 (± 0.8) 96.25 (± 3.2) - 32.05 
5 189.30 (± 3.0) 128.41 (± 2.7) 23.56 (± 0.4) 14.20 (± 2.5) - 53.75 
3 and 5 94.47 (± 2.0) 88.61 (± 3.9) 24.69 (± 0.4) 25.68 (± 0.8) - 43.00 
All DLS graphs, DLS correlation functions and zeta potential graphs can be found in the 
appendix (Figures 126-145). 
2.4.6 Surface tension and critical micelle concentration (CMC)  
The CMC is the concentration at which the addition of any extra amphiphile will result in the 
formation of aggregates in solution,111 however, the aggregates can be present before the CMC is 
reached. The CMC will be determined as the concentration at which any addition of compound will 
no longer decrease the surface tension and has been found that a low CMC forms stable micelles.112 
The surfactant properties of the amphiphiles was tested using a pendant drop method in a H2O: 
EtOH 19:1 solution, corresponding to the DLS and zeta potential studies. Due to time constraints, 
the CMC for the mixture of compound 3 and 5 is not available, however, it will be done in the future. 
2.4.6.1 Results and discussion 
The CMC values were calculated for compounds 3-5 and the mixture (Table 12), it shows the 
following trend 3 > 4 > 5. Comparing the CMC to the zeta potential as the trend for zeta potential 
is as followed, 3 > 4 > 5, this shows the CMC and zeta potential have a positive correlation. The 
surface tension at CMC for compound 3 is the lowest, indicating that compound 3 is the best 
surfactant. 
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Table 9 – Overview of CMC and surface tension (obtained at CMC) measurements for compounds 3-5 at 25°C. 
Compound CMC (mM) Surface tension at CMC (mN/ m) 
3 24.98 53.70 
4 6.00 56.87 
5 4.24 57.70 
The 1:1 mixture was not studied with this technique due to time constraints, the CMC for the 
mixture will be done in the future. All CMC graphs can be found in the appendix (Figures 146-148). 
2.5 Low level in-silico modelling 
Computational chemistry is often combined with chemistry to help form hypothesis for 
problems that arise. An example of computational chemistry supporting chemistry is within 
synthetic chemistry, the electrostatic potential map can be calculated to help visualise the 
electronegative and electropositive areas of a compound and help support the hypothesis of the 
molecular interactions.113 Herein, computational chemistry will be used to calculate the 
electrostatic potential maps for compounds 3-10 using Spartan 16” with energy minimised semi-
empirical PM6 modelling methods to derive comparative Emax and Emin values.114 
2.5.1 Results and discussion 
The electrostatic potential maps show that for compound 3 the most negative point on the 
surface (Emin) of the molecules is predominately at the sulfonate (Figure 41), which is expected as 
the negative charge is carried there, however, there is also a negative point on the surface around 
the urea oxygen. Hence, the sulfonate and urea oxygen are the areas which are likely to be HBA 
groups. The most positive points on the surface (Emax) are compound 3 is at the urea NHs, amide 
NH and around the DNA moiety, therefore, these areas are likely to be HBD groups. This trend also 
occurs within compounds 4 and 5 (Figures 150-151). These electrostatic potential maps correlate 
with the crystal structures of compounds 4 and 5 as we see interactions between the sulfonate-
urea, the sulfonate-DNA moiety and the sulfonate-amide group (Figures 19-20). 
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Figure 41 – Electrostatic potential map calculated for the anionic component of 3. Emax and Emin values depicted in the 
Figure legends are given in kJ/mol. 
The electrostatic potential map for compound 7 shows that the Emin occurs around nitro 
functionality and amide oxygen (Figure 42), while the Emax occurs around the amide NH and nitrogen 
on the nitropyridine. However, when comparing to the crystal structure, it self-associates through 
the amide functionality showing that the Emin and Emax lies more towards the amide as opposed to 
the nitropyridine moiety. This trend is also apparent for compound 8 (Figure 154), however, a 
crystal structure was not obtained for compound 8, therefore, it is hypothesised that it would self-
associate through a similar motif. 
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Figure 42 – Electrostatic potential map calculated for compound 7. Emax and Emin values depicted in the Figure legends 
are given in kJ/mol. 
To conclude, the Emin areas are likely to be HBA groups while the Emax areas are likely to be HBD 
groups. It is hypothesised that low-level computational chemistry can be used to help predict where 
the hydrogen bonding will occur within the solid state.  
2.6 Antimicrobial properties 
Antimicrobial resistance is an ongoing problem and it is predicted to overtake cancer in the 
number of deaths by 2050,115 therefore, new antimicrobials must be discovered or the current 
antimicrobials must be improved to combat this problem. Antibiotics are often overused and 
misused, leading to a greater increase in antibiotic resistance.116 Bacteria can be classified into two 
types; Gram positive which have a single cell membrane and a thick cell wall, and Gram negative 
which have two cell membranes and a thin cell wall between the membranes. The amphiphiles will 
be tested on both types of bacteria, S.aureus for Gram positive and E.coli for Gram negative 
bacteria. The compounds will be screened at 3.33 mM, using a micro broth dilution method.117 
Compounds 3-5 and the 1:1 mixture were screened against S.aureus and E.coli, if a compound 
inhibits more than 10% of growth, the compound would be considered to show antimicrobial 
activity and will be taken further to calculate the MIC50. This study was conducted by Jess Boles. 
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2.6.1 Results and discussion 
The screening results for the compounds shows that for both S.aureus and E.coli, only 
compound 3 inhibits more than 10 % of growth for both types of bacteria (Figures 43-44), therefore 
only compound 3 will be taken further to calculate the MIC50.  
 
Figure 43 – Averaged growth curves created from absorbance readings of MRSA in the presence of compounds 3, 4, 5 
and 3 + 5 in combination at a total concentration of 3.3 mM.  
 
Figure 44 – Averaged growth curves created from absorbance readings of E. coli DH10B in the presence of compounds 
3, 4, 5 and 3 + 5 in combination at a total concentration of 3.3 mM. 
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2.7 Conclusion 
In conclusion, two novel DNA inspired amphiphiles were synthesised, characterised and self-
association properties were studied and shown to be in line with previously published methods. 
Novel comparative DNA inspired compounds were also synthesised to break down the complex 
interactions within the amphiphiles. Solid state, gas phase and solution state experiments showed 
the amphiphiles can self-associate and form low complex species in DMSO or aggregate into stable 
micelles in aqueous solutions. Only the thymine inspired amphiphile showed signs of antimicrobial 
activity against both S.aureus and E.coli. The titration results conclude that the adenine analogue 
amphiphile shows no interaction between the thymine comparative compound, this is 
hypothesised to be due to the competitive interactions of the functional groups between the 
compounds negating any changes.  
3. Future works 
The self-association and association properties of these novel amphiphiles were studied, they 
showed the formation of aggregates. They shared similar properties to previously published results 
from Hiscock et al. Hence, the future works that will be carried out are as followed: 
 As Compound 3 passed the antimicrobial screening, it will be taken further and the 
MIC50 will be calculated for Gram positive (S.aureus) and Gram negative (E.coli) 
bacteria. 
 DLS and DOSY studies will be carried out for compound 3 in DMSO. The CMC for the 
1:1 mixture of compounds 3 and 5 will be completed and self-association studies for 
compounds 6 and 7 will be carried out. A crystal structure of compound 8 will be 
obtained. 
 Synthesising the adenine inspired amphiphile and test the association properties with 
the thymine inspired amphiphile (Figure 45A). 
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 Synthesising a guanine and cytosine inspired amphiphiles and testing association 
properties between them (Figure 45 B, C). 
 
Figure 45 – Theoretical structures of DNA inspired amphiphiles A) adenine B) cytosine C) guanine. 
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4. Experimental techniques 
4.1 General remarks 
All reactions were performed under a slight positive pressure of nitrogen using oven-dried 
glassware. NMR spectra were determined using a Bruker AV2 400 MHz or Bruker AVNEO 400 MHz 
spectrometer with the chemical shifts reported in parts per million (ppm), calibrated to the centre 
of the solvent peak set. The data was processed using ACD Labs, all solvents and starting materials 
were purchased from commercial sources where available. High-resolution mass spectra were 
collected using a Bruker micrOTOF-Q mass spectrometer. Melting points were recorded in open 
capillaries using a Stuart SMP10 melting point apparatus. Infrared (IR) spectra were recorded using 
a Shimadzu IR-Affinity 1, the data was analysed in wavenumbers (cm-1) using IRsolution software. 
DLS and Zeta Potential studies were carried out using Anton Paar LitesizerTM 500 and processed 
using KalliopeTM Professional. 
4.2 DLS studies 
Studies conducted with compounds 4 and 5 were prepared in series with an aliquot of the most 
concentrated solution undergoing serial dilution. Sample sizes were kept to 1 mL. All solvents used 
for DLS studies were filtered to remove particulates from the solvents. Samples were heated to the 
appropriate temperature and allowed to equilibrate for 1 hour and then a series of 10 ‘runs’ were 
performed with each sample to give enough data to derive an appropriate average. In some 
instances, the raw correlation data indicated that a greater amount of time may be needed for the 
samples to reach a stable state. For this reason, only the last 9 ‘runs’ were included in the average 
size distribution calculations. 
4.3 Zeta potential studies 
All solvents used for Zeta potential studies were filtered to remove particulates from the 
solvents. Samples were heated to the appropriate temperature and allowed to equilibrate for 1 
hour and then a series of 10 ‘runs’ at 25 ⁰C were performed with each sample to give enough data 
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to derive an appropriate average. In some instances, the raw correlation data indicated that a 
greater amount of time may be needed for the samples to reach a stable state. For this reason, only 
the last 9 ‘runs’ were included in the average size distribution calculations. 
4.4 High-resolution mass spectra studies 
Samples were dissolved in HPLC-grade methanol at a concentration of 1 mg/mL before being 
diluted 1 in 100 in methanol. 10 μL of the sample was injected into a flowing stream of 10 mM 
ammonium acetate in 95% methanol in water (flow rate: 0.02 mL/min) and the flow directed into 
the electrospray source of the mass spectrometer. Mass spectra were acquired in the negative ion 
mode and data processed in Bruker’s Compass Data Analysis software. 
4.5 Self-association and association constant calculation 
All association constants were calculated using the freely available bindfit programme 
(http://app.supramolecular.org/bindfit/). All the data relating to the calculation of the association 
constants can be accessed online, through the links given for each complexation event. 
4.6 Single-crystal X-ray studies 
A suitable crystal of each amphiphile was selected and mounted on a Rigaku Oxford Diffraction 
Supernova diffractometer. Data were collected using Cu Kα radiation at 293 K. Structures were 
solved with the ShelXT118 or ShelXS structure solution programs via Direct Methods and refined with 
ShelXL119 by Least Squares minimisation. Olex2120 was used as an interface to all ShelX programs 
(CCDC 1866274-1866275) 
4. Synthesis 
Compound 1: This compound was synthesised in line with our previously published methods. 
Proton NMR were found to match our previously published values.91 1H NMR (400 MHz, DMSO-d6): 
0.93 (t, J = 7.34 Hz, 12H), 1.31 (s, J = 7.36 Hz, 8H), 1.56 (m, 8H), 3.16 (m, 8H), 3.92 (d, J = 6.00 Hz, 
2H), 6.99 (br s, NH), 7.58 (d, J = 9.20 Hz, 2H), 8.09 (d, J = 9.28 Hz, 2H), 9.56 (br s, NH). 
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Compound 2: This compound was synthesised in line with our previously published methods. 
Proton NMR were found to match our previously published values.92 1H NMR (400 MHz, DMSO-d6): 
0.93 (t, J = 7.24 Hz, 12H), 1.30 (m, 8H), 1.56 (m, 8H), 3.16 (m, 8H), 3.84 (d, J = 5.85 Hz, 2H), 4.62 (br 
s, 2H, NH2), 6.23 (m, NH), 6.45 (d, J = 8.68 Hz, 2H), 7.00 (d, J = 8.72 Hz, 2H), 8.26 (br s, NH). 
Compound 3: HOSu (0.118 g, 1.027 mM) was added to a stirring solution of thymine-1-acetic 
acid (0.190 g, 1.027 mM) and compound 2 (0.50 g, 1.027 mM) in DMF (2 mL) in an ice-bath for 30 
mins. After the 30 mins DCC (0.254 g, 1.233 mM) in DMF (2 mL) was added to the solution and taken 
out of the ice bath and left stirring overnight. Water (10 mL) was added, the precipitate was filtered 
and removed. The water was taken to dryness and the solid was dissolved DCM (20 mL). The 
precipitate was filtered, collected and dissolved in ethanol (20 mL). The precipitate was filtered, 
removed and the ethanol was taken to dryness. Pure product was obtained by precipitation with 
acetone yielding a white solid. Yield: 54% (0.36 g, 0.55 mM); 1H NMR (400 MHz, DMSO-d6): 0.93 (t, 
J = 14.60 Hz, 12H), 1.30 (m, 8H), 1.54 (m, 8H), 1.76 (s, 3H), 3.16 (m, 8H), 3.84 (d, J = 5.88 Hz, 2H), 
4.46 (s, 2H), 6.40 (br s, NH), 7.30 (d, J = 8.88 Hz, 2H), 7.41 (d, J = 9.08 Hz, 2H), 7.51 (s, 1H), 8.70 (s, 
NH), 10.12 (s, NH), 11.34(s, NH); 
Compound 4: EDC (0.087 g, 0.452 mM) was added to a stirring solution 2-nitroisonicotinic acid 
(0.07 g, 0.411 mM) and Compound 2 (0.20 g, 0.411 mM) in DMF (2 mL) in an ice-bath overnight. 
Water (10 mL) was added and separated with ethyl acetate (2 x 20 mL). The organic layer was taken 
to dryness, and the pure product was obtained by precipitation with water yielding a bright yellow 
solid. Yield: 51% (0.133 g, 0.209 mM); Melting point: 200°C; 1H NMR (400 MHz, DMSO-d6): 0.93 (t, 
J = 14.68 Hz, 12H), 1.30 (m, 8H), 1.56 (m, 8H), 3.16 (m, 8H), 3.87 (d, J = 5.76 Hz, 2H), 6.47 (m, NH), 
7.40 (d, J = 8.80 Hz, 2H), 7.63 (d, J = 8.92 Hz, 2H), 8.36 (d, J = 4.88 Hz, 1H), 8.78 (s, 1H), 8.81 (br s, 
NH), 8.87 (d, J = 4.96 Hz, 1H), 10.67 (br s, NH); 13C{1H} NMR (100 MHz, DMSO-d6): δ: 13.5 (CH3), 19.2 
(CH2), 23.1 (CH2), 56.1 (CH2), 57.5 (CH3), 116.2 (CH), 117.6 (CH), 121.2 (CH), 127.8 (CH), 131.6 (C), 
137.4 (C), 146.4 (C), 149.7 (CH), 154.6 (C), 157.0 (C), 161.2 (C); IR (film): ν = 3333 (NH stretch), 1693 
(C=O stretch), 1520 & 1312 (NO2 stretch) ; HRMS for the sulfonate-urea ion (C14H12N5O7S) (ESI-): 
m/z: act: 394.0440 [M]- cal: 394.3385 [M]-. 
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Compound 5: Compound 4 (3.50 g, 0.55 mM), hydrazine hydrate (1.00 mL, 28.75 mM) and 
Pd/C 10 % (0.10 g) were heated at reflux overnight in ethanol (20 mL). The Pd/C 10 % was removed 
by filtration and the remaining solution taken to dryness. Pure product was obtained by 
precipitation with acetone. Yield: 84% (2.80 g, 0.46 mM); Melting point: >200°C; 1H NMR (400 MHz, 
DMSO-d6): 0.93 (t, J = 7.24 Hz, 12H), 1.30 (m, 8H), 1.56 (m, 8H), 3.16 (m, 8H), 3.85 (d, J = 5.60 Hz, 
2H), 6.20 (s, NH2), 6.42 (m, NH), 6.85 (s, 1H), 6.91 (d, J = 4.96 Hz, 1H), 7.33 (d, J = 8.68 Hz, 2H), 7.58 
(d, J = 8.64 Hz, 2H), 8.02 (d, J = 5.16 Hz, 1H), 8.74 (br s, NH), 10.15 (s, NH); 13C{1H} NMR (100 MHz, 
DMSO-d6): δ: 13.6 (CH3), 19.2 (CH2), 23.1 (CH2), 56.1 (CH2), 57.5 (CH3), 106.2 (CH), 109.4 (CH), 117.6 
(CH), 121.0 (CH), 132.3 (C), 136.8 (C), 143.5 (C), 148.4 (CH), 154.6 (C), 160.3 (C), 164.4 (C); IR (film): 
ν = 3329 (NH stretch), 1676 (C=O stretch); HRMS for the sulfonate-urea ion (C14H14N5O5S) (ESI-): m/z: 
act: 364.0702 [M]- cal: 364.3565 [M]-. 
Compound 6: This compound was synthesised in line with our previously published methods. 
Proton NMR were found to match our previously published values.96 1H NMR (400 MHz, DMSO-d6): 
1.77 (s, 3H), 4.57 (s, 2H), 7.53 (s, 1H), 7.81 (d, J = 9.28 Hz, 2H), 8.24 (d, J = 9.28 Hz, 2H), 10.92 (s, 
NH), 11.41 (s, NH). 
Compound 7: 2-nitroisonicotinic acid (0.37 g, 2.17 mmol) was added to a stirred solution of CDI 
(0.387 g, 2.38 mmol) in chloroform (15 mL) and heated at reflux at 70 ͦC under nitrogen for 4 hours. 
4-(trifluoromethyl) aniline (0.45 mL, 2.17 mmol) was added to the mixture and left overnight. Crude 
product was diluted in chloroform (20 mL) and water (3 x 20 mL). The organic layer was reduced in 
volume and pure product was obtained by precipitation with hexane. Yield: 54% (0.366 g, 1.18 mM); 
Melting point: 195°C; 1H NMR (400 MHz, DMSO-d6): 7. 77 (d, J = 8.60 Hz, 2H), 8.01 (d, J = 8.52 Hz, 
2H), 8.37 (dd, J = 1.36, 4.94 Hz, 1H), 8.80 (s, 1H), 8.90 (d, J = 4.88 Hz, 1H), 11.09 (s, NH); 13C{1H} NMR 
(100 MHz, DMSO-d6): δ: 116.3 (ArCH), 120.5 (ArCH), 124.5 (CF3, J = 31.69 Hz), 126.1 (ArCH, J = 269.99 
Hz), 128.0 (ArCH, J = 3.79 Hz), 141.9 (ArC), 145.8 (ArC), 149.9 (ArCH), 156.9 (ArC), 162.4 (C=O); IR 
(film): ν = 3333 (NH stretch), 1662 (C=O stretch), 1535 & 1327 (N-O stretch); HRMS for the sulfonate-
urea ion (C13H8F3N3O3) (ESI-): m/z: act: 310.0433 [M]- cal: 311.2202 [M]-. 
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Compound 8: Hydrazine hydrate (0.5 mL, 10 mM) was added to a stirring solution of Compound 
7 (0.200 g, 0.64 mM) and Pd/C (0.05 g, mM) in ethanol (20 mL) and was heated to 80 ͦC. The solution 
was filtered and taken to dryness. Yield: 75% (0.136g, 0.48 mM); Melting point: >200°C; 1H NMR 
(400 MHz, DMSO-d6): 6.27 (br s, NH2), 6.88 (s, 1H), 6.93 (m, 1H), 7.72 (d, J = 8.52 Hz, 2H), 7.98 (d, J 
= 8.60 Hz, 2H), 8.07 (d, J = 5.24 Hz, 1H) 10.62 (br s, NH); 13C{1H} NMR (100 MHz, DMSO-d6): δ: 106.3 
(ArCH), 109.4 (ArCH), 120.2 (ArCH), 123.0 (q, J = 31.87 Hz, ArC), 123.9 (q, J = 270.00 Hz, CF3), 126.0 
(q, J = 3.79 Hz, ArCH), 142.5 (ArC), 143.0 (ArC), 148.4 (ArCH), 160.2 (C=O), 165.5 (ArC); IR (film): ν = 
3304 (NH stretch), 1676 (C=O stretch); HRMS for the sulfonate-urea ion (C13H10F3N3O) (ESI-): m/z: 
act: 280.0820 [M]- cal: 281.2382 [M]-. 
Compound 9: This compound was synthesised in line with our previously published methods. 
Proton NMR were found to match our previously published values.96 1H NMR (400 MHz, DMSO-d6): 
0.89 (t, J = 7.24 Hz, 3H), 1.30 (m, 2H), 1.41 (m, 2H), 3.10 (q, J = 5.76 Hz, 2H), 6.41 (m, NH), 7.61 (d, J 
= 9.36 Hz, 2H), 8.12 (d, J = 9.36 Hz, 2H), 9.19 (br s, NH).  
Compound 10: This compound was synthesised in line with previously published methods. 
Proton NMR were found to match previously published values.121 1H NMR (400 MHz, DMSO-d6): 
1.75 (d, J = 1.10 Hz, 3H), 3.68 (s, 3H), 4.48 (s, 2H), 7.50 (d, J = 1.2 Hz, 1H), 11.43 (br s, NH). 
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6. Appendix  
6.1 Characterisation NMR 
 
Figure 46 – 1H NMR of Compound 1 in DMSO - d6. 
 
Figure 47 – Enlarged 1H NMR of Compound 1 in DMSO - d6. 
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Figure 48 – Enlarged 1H NMR of Compound 1 in DMSO - d6. 
 
Figure 49 – 1H NMR of Compound 2 in DMSO - d6. 
 
Figure 50 – Enlarged 1H NMR of Compound 2 in DMSO - d6.  
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Figure 51 – Enlarged 1H NMR of Compound 2 in DMSO - d6. 
 
Figure 52 – 1H NMR of Compound 3 in DMSO - d6. 
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Figure 53 – Enlarged 1H NMR of Compound 3 in DMSO - d6. 
 
Figure 54 – Enlarged 1H NMR of Compound 3 in DMSO - d6. 
 
Figure 55 – 1H NMR of Compound 4 in DMSO - d6. 
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Figure 56 – Enlarged 1H NMR of Compound 4 in DMSO - d6. 
 
Figure 57 – Enlarged 1H NMR of Compound 4 in DMSO - d6. 
 
Figure 58 – 13C NMR of Compound 4 in DMSO - d6. 
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Figure 59 – Enlarged 13C NMR of Compound 4 in DMSO - d6. 
 
Figure 60 – Enlarged 13C NMR of Compound 4 in DMSO - d6. 
 
Figure 61 – 1H NMR of Compound 5 in DMSO - d6. 
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Figure 62 – Enlarged 1H NMR of Compound 5 in DMSO - d6. 
 
Figure 63 – Enlarged 1H NMR of Compound 5 in DMSO - d6. 
 
Figure 64 – 13C NMR of Compound 5 in DMSO - d6. 
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Figure 65 – Enlarged 13C NMR of Compound 5 in DMSO - d6. 
 
Figure 66 – Enlarged 13C NMR of Compound 5 in DMSO - d6. 
 
Figure 67 – 1H NMR of Compound 6 in DMSO - d6. 
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Figure 68 – Enlarged 1H NMR of Compound 6 in DMSO - d6. 
 
Figure 69 – Enlarged 1H NMR of Compound 6 in DMSO - d6. 
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Figure 70 – 13C NMR of Compound 6 in DMSO - d6. 
 
Figure 71 – Enlarged 13C NMR of Compound 6 in DMSO - d6. 
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Figure 72 – Enlarged 13C NMR of Compound 6 in DMSO - d6. 
 
Figure 73 – 1H NMR of Compound 7 in DMSO - d6. 
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Figure 74 – Enlarged 1H NMR of Compound 7 in DMSO - d6. 
 
Figure 75 – 13C NMR of Compound 7 in DMSO - d6. 
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Figure 76 – Enlarged 13C NMR of Compound 7 in DMSO - d6. 
 
Figure 77 – 1H NMR of Compound 8 in DMSO - d6. 
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Figure 78 – Enlarged 1H NMR of Compound 8 in DMSO - d6. 
 
Figure 79 – 13C NMR of Compound 8 in DMSO - d6. 
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Figure 80 – Enlarged 13C NMR of Compound 8 in DMSO - d6. 
 
Figure 81 – 1H NMR of Compound 9 in DMSO - d6. 
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Figure 82 – Enlarged 1H NMR of Compound 9 in DMSO - d6. 
 
Figure 83 – Enlarged 1H NMR of Compound 9 in DMSO - d6. 
 
Figure 84 – 1H NMR of Compound 10 in DMSO - d6. 
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6.2 Single crystal X-ray structures 
 
Figure 85 – Single crystal X-ray structure of compound 4. 
 
Figure 86 – Single crystal X-ray structure of compound 5. 
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Figure 87 – Single crystal X-ray structure of compound 7. 
 
Figure 88 – Single crystal X-ray structure of compound 9. 
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6.3 Mass spectrum data 
 
Figure 89 – ESI- mass spectrum collected for compound 3. 
 
Figure 90 – ESI- mass spectrum collected for compound 3. 
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Figure 91 – ESI- mass spectrum collected for compound 4. 
 
Figure 92 – ESI- mass spectrum collected for compound 4. 
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Figure 93 – ESI- mass spectrum collected for compound 5. 
 
Figure 94 – ESI- mass spectrum collected for compound 5. 
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Figure 95 – ESI- mass spectrum collected for compound 6. 
 
Figure 96 – ESI- mass spectrum collected for compound 6. 
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Figure 97 – ESI- mass spectrum collected for compound 7. 
 
Figure 98 – ESI- mass spectrum collected for compound 7. 
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Figure 99 – ESI- mass spectrum collected for compound 8. 
 
Figure 100 – ESI- mass spectrum collected for compound 8. 
Table 10 – High Resolution mass spectrometry theoretical and experimentally derived values for compounds 3-5. 
Compound 
m/z [M]- m/z [M + M + H+]- 
Theoretical Actual Theoretical Actual 
3 410.3815 410.0755 821.7700 821.1591 
4 394.3385 394.0440 789.6840 789.0951 
5 364.3565 364.0702 729.7200 729.1471 
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Table 11 – High Resolution mass spectrometry theoretical and experimentally derived values for compounds 6-8. 
Compound 
m/z [M – H+]- m/z [M + M]- 
Theoretical Actual Theoretical Actual 
6 303.2550 303.0863 607.5170 607.1776 
7 310.2132 310.0433 621.4334 621.0916 
8 280.2312 280.0820 561.4694 561.1680 
6.4 1H NMR quantitative studies 
 
Figure 101 – 1H NMR spectrum (d1 = 60 s) of compound 3 (0.0364 g, 111.12 mM) and DCM (5 µl, 0.08 mM) in DMSO-d6. 
6% of compound observed upon comparative signal integration. 
11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
1.882.87
Page | 91 
 
 
Figure 102 – 1H NMR spectrum (d1 = 60 s) of compound 3 (0.00197 g, 6.00 mM) and EtOH (5 µl, 0.43 mM) in D2O. No 
apparent loss of compound observed upon comparative signal integration. 
 
Figure 103 – 1H NMR spectrum (d1 = 60 s) of compound 4 (0.0354 g, 111.12 mM) and DCM (5 µl, 0.08 mM) in DMSO-d6. 
No apparent loss of compound observed upon comparative signal integration. 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
285.002.042.091.02
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Figure 104 – 1H NMR spectrum (d1 = 60 s) of compound 4 (0.00190 g, 6.00 mM) and EtOH (5 µl, 0.43 mM) in D2O 29% 
loss of compound observed upon comparative signal integration. 
 
Figure 105 – 1H NMR spectrum (d1 = 60 s) of compound 5 (0.0337 g, 111.12 mM) and DCM (5 µl, 0.08 mM) in DMSO-d6. 
No apparent loss of compound observed upon comparative signal integration. 
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Figure 106 – 1H NMR spectrum (d1 = 60 s) of compound 5 (0.00184 g, 6.00 mM) and EtOH (5 µl, 0.43 mM) in D2O. 32% 
loss of compound observed upon comparative signal integration. 
 
Figure 107 – 1H NMR spectrum (d1 = 60 s) of compound 3 (0.01814 g, 55.56 mM), compound 5 (0.01687 g, 55.56 mM) 
and DCM (5 µl, 0.08 mM) in DMSO-d6. 7 % loss of compound observed upon comparative signal integration. 
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
5.768.40
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Figure 108 – 1H NMR spectrum (d1 = 60 s) of compound 3 (0.00196 g, 3.00 mM), compound 5 (0.00183 g, 3.00 mM) and 
DCM (5 µl, 0.08 mM) in D2O. 58 % loss of compound observed upon comparative signal integration. 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
286.453.80
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6.5 1H NMR DOSY studies 
 
Figure 109 – 1H DOSY NMR of compound 4 (111.12 mM) in DMSO-d6 conducted at 298.15 K. Anionic component 
highlighted in blue, TBA counter cation highlighted in red. 
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Table 12 – Diffusion data obtained from 1H DOSY NMR of compound 4 (111.12 mM) in DMSO-d6 conducted at 298.15 K. 
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Figure 110 – 1H DOSY NMR of compound 5 (111.12 mM) in DMSO-d6 conducted at 298.15 K. Anionic component 
highlighted in blue, TBA counter cation highlighted in red. 
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Table 13 – Diffusion data obtained from 1H DOSY NMR of compound 5 (111.12 mM) in DMSO-d6 conducted at 298.15 K. 
 
Table 14 – Calculated hydrodynamic diameter for compounds 4 and 5 in DMSO-d6 conducted at 298.15 K. 
Compound Anion (nm) Cation (nm) 
4 1.78 1.28 
5 1.94 1.37 
6.6 1H NMR self-association studies 
 
Figure 111 – 1H NMR stack plot of compound 4 in a DMSO- d6 0.5 % H2O solution. Samples were prepared in series with 
an aliquot of the most concentrated solution undergoing serial dilution. 
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Figure 112 – Enlarged 1H NMR stack plot of compound 4 in a DMSO- d6 0.5 % H2O solution. Samples were prepared in 
series with an aliquot of the most concentrated solution undergoing serial dilution. 
 
Figure 113 – Graph illustrating the 1H NMR down-field change in chemical shift of NH resonances with increasing 
concentration of compound 4 in DMSO- d6 w/ 0.5 % H2O (298.15 K). 
Self-association constant calculation 
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Table 15 – Dilution study of compound 4 in DMSO-d6 w/ 0.5 % H2O. Values calculated from data gathered from 2 NHs. 
Compound 
EK Model (M-1) CoEK Model (M-1) 
Ke Kdim Ke Kdim ρ 
4 1.41 (± 1.5 %) 0.71 (± 0.7 %) 10.91 (± 3.4 %) 5.45 (± 1.7 %) 0.30 (± 10.0 %) 
Link for EK http://app.supramolecular.org/bindfit/view/090bee18-4a16-4728-9d3a-565b04666500 
Link for CoEK http://app.supramolecular.org/bindfit/view/573b0ca3-687a-437f-bff5-3ded4a748198 
 
Figure 114 – 1H NMR stack plot of compound 5 in a DMSO-d6 0.5 % H2O solution. Samples were prepared in series with 
an aliquot of the most concentrated solution undergoing serial dilution. 
 
Figure 115 – Enlarged 1H NMR stack plot of compound 5 in a DMSO-d6 0.5 % H2O solution. Samples were prepared in 
series with an aliquot of the most concentrated solution undergoing serial dilution. 
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Figure 116 – Graph illustrating the 1H NMR down-field change in chemical shift of urea NH resonances with increasing 
concentration of compound 5 in DMSO-d6 0.5 % H2O (298.15 K). 
Self-association constant calculation 
Table 16 – Dilution study of compound 5 in DMSO-d6 5 % H2O. Values calculated from data gathered from 2 NH. 
Compound 
EK Model (M-1) CoEK Model (M-1) 
Ke Kdim Ke Kdim ρ 
5 1.78 (± 0.6 %) 0.89 (± 0.3 %) 8.32 (± 3.1 %) 4.16 (± 1.6 %)  0.50 (± 5.2 %) 
Link for EK http://app.supramolecular.org/bindfit/view/005255d3-873e-49e1-b066-d6b551ddc6fd 
Link for CoEK http://app.supramolecular.org/bindfit/view/96557a3e-c430-4e14-9bc4-11cc00d92277 
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6.7 1H NMR titration studies 
 
Figure 117 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 4 (host) with 
increasing the concentration of compound 10 (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
 
Figure 118 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 4 (host) with 
increasing the concentration of TBA+ HSO4- (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
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Figure 119 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 5 (host) with 
increasing the concentration of compound 10 (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
 
Figure 120 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 5 (host) with 
increasing the concentration of TBA+ HSO4- (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
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Figure 121 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 7 (host) with 
increasing the concentration of compound 10 (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
 
Figure 122 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 7 (host) with 
increasing the concentration of TBA+ HSO4- (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
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Table 17 – Association constants (M-1) calculated for each NH in compound 7 (host) titrated against TBA+ HSO4- (guest) in 
a DMSO-d6 – 0.5% H2O solution (298 K). 
Host: Guest 1: 1 1: 2 2: 1 
NH K K11 K12 K11 K21 
Circle 
3.35 (± 1.1 %) 
436846684486 
(± 8309238 %) 
3.49 (± 1.8 %) -48.9 (± 9.0 %) 
-24.69 (± - 8.1 
%) 
Link to 1:1 http://app.supramolecular.org/bindfit/view/f66937c8-9eab-4632-a8ff-b4085f79f1fc 
Link to 1:2 http://app.supramolecular.org/bindfit/view/0c7d2b13-9028-4787-a84c-f145c7f474d3 
Link to 2:1 http://app.supramolecular.org/bindfit/view/06b6b7a0-a00e-417f-bcf3-c8dec846d20d 
a – association constant too large (> 105 M-1) b – negative association constant. 
 
Figure 123 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 8 (host) with 
increasing the concentration of compound 10 (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
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Figure 124 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 8 (host) with 
increasing the concentration of TBA+ HSO4- (guest) in a DMSO-d6 – 0.5% H2O solution (298 K).. 
 
Figure 125 – A graph showing the downfield 1H NMR change in chemical shift for the NHs of compound 9 (host) with 
increasing the concentration of compound 10 (guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
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Table 18 – Association constants (M-1) calculated for each NH in compound 9 (host) titrated against compound 10 
(guest) in a DMSO-d6 – 0.5% H2O solution (298 K). 
Host: 
Guest 
1: 1 1: 2 2: 1 
NH K K11 K12 K11 K21 
Circle 
25.92 (± 5.7 %) 
2010437381651813 
(± 169434405 %) 
20.46 (± 9.7 %) 
56.18  
(± 97.5 %) 
639.76  
(± 112.9 %) 
Link to 1:1 http://app.supramolecular.org/bindfit/view/b5b7f1f9-f026-4ac7-a3ff-349589218af0 
Link to 1:2 http://app.supramolecular.org/bindfit/view/c423c643-5207-4222-bd8f-9932be63f86f 
Link to 2:1 http://app.supramolecular.org/bindfit/view/cd5c2e7e-4eb6-4786-a37e-f6c106443e77 
Triangle 
17.33 (± 4.8 %) 38.31 (± 9.3 %) 
-5.25  
(± -24.1 %) 
0.00881 
(± 104.1 %) 
5400616 
(± 115.3 %) 
Link to 1:1 http://app.supramolecular.org/bindfit/view/2346a76b-c509-42ab-9a0c-df612552486e 
Link to 1:2 http://app.supramolecular.org/bindfit/view/b9d513ac-beb9-4d35-a767-24cdafe748d7 
Link to 2:1 http://app.supramolecular.org/bindfit/view/27939811-fa26-4a78-896f-bd0b27b0e951 
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6.8 DLS data 
 
Figure 126 – Average intensity particle size distribution, calculated from 9 DLS runs, of aggregates formed by dissolving 
compound 3 at a concentration of 3.00 mM in a solution of EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C. 
 
Figure 127 – Correlation function data for 9 DLS runs of compound 3 at a concentration of 3.00 mM in a solution of 
EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C. 
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Figure 128 – Average intensity particle size distribution, calculated from 10 DLS runs, of aggregates formed by dissolving 
compound 3 at a concentration of 0.30 mM in a solution of EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C. 
 
Figure 129 – Correlation function data for 10 DLS runs of compound 3 at a concentration of 0.30 mM in a solution of 
EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C. 
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Figure 130 – Average intensity particle size distribution, calculated from 10 DLS runs, of aggregates formed by dissolving 
compound 4 at a concentration of 3.00 mM in a solution of EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C.  
 
Figure 131 – Correlation function data for 10 DLS runs of compound 4 at a concentration of 3.00 mM in a solution of 
EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C. 
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Figure 132 – Average intensity particle size distribution, calculated from 10 DLS runs, of aggregates formed by dissolving 
compound 4 at a concentration of 0.30 mM in a solution of EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C.  
 
Figure 133 – Correlation function data for 10 DLS runs of compounds 4 at a concentration of 0.30 mM in a solution of 
EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C. 
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Figure 134 – Average intensity particle size distribution, calculated from 10 DLS runs, of aggregates formed by dissolving 
compound 5 at a concentration of 3.00 mM in a solution of EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C. 
 
Figure 135 – Correlation function data for 10 DLS runs of compounds 5 at a concentration of 3.00 mM in a solution of 
EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C. 
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Figure 136 – Average intensity particle size distribution, calculated from 10 DLS runs, of aggregates formed by dissolving 
compound 5 at a concentration of 0.30 mM in a solution of EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C. 
 
Figure 137 – Correlation function data for 10 DLS runs of compound 5 at a concentration of 0.30 mM in a solution of 
EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C. 
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Figure 138 – Average intensity particle size distribution, calculated from 8 DLS runs, of aggregates formed by dissolving 
compounds 3 and 5 at a concentration of 3.00 mM in a solution of EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 
25 ⁰C. 
 
Figure 139 – Correlation function data for 10 DLS runs of a mixture of compounds 3 and 5 at a total concentration of 
3.00 mM in a solution of EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C 
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Figure 140 – Average intensity particle size distribution, calculated from 10 DLS runs, of aggregates formed by dissolving 
compounds 3 and 5 at a concentration of 0.30 mM in a solution of EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 
25 ⁰C. 
 
Figure 141 – Correlation function data for 10 DLS runs of a mixture of compounds 3 and 5 at a total concentration of 
0.30 mM in a solution of EtOH: H2O 1:19, after heating to 40 ⁰C and cooling to 25 ⁰C 
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Table 19 – Average intensity particle size distribution for compounds 4, 5 and a mixture of compounds 3 and 5, 
calculated from 10 DLS runs at 3.00 mM and 0.3 mM. Samples were prepared in series, with an aliquot of the most 
concentrated solution undergoing serial dilution and measured after heating to 40 ⁰C and cooling to 25 ⁰C. 
Compound 
Peak maxima (nm) PDI (%) 
3 mM 0.3 mM 3 mM 0.3 mM 
3 147.23 (± 7.4) 126.23 (± 2.85) 25.02 (± 0.7) 21.79 (± 0.3) 
4 230.97 (± 12.81) 222.45 (± 9.70) 26.13 (± 0.78) 96.25 (± 3.23) 
5 189.30 (± 2.96) 128.41 (± 2.66) 23.56 (± 0.41) 14.20 (± 2.52) 
3 and 5 94.47 (± 2.0) 88.61 (± 3.9) 24.69 (± 0.4) 25.68 (± 0.8) 
6.9 Zeta potential 
 
Figure 142 – The average zeta potential distribution calculated using 10 runs for compound 3 (3 mM) in an EtOH: H2O 
(1:19) solution at 298K. 
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Figure 143 – The average zeta potential distribution calculated using 10 runs for compound 4 (3 mM) in an EtOH: H2O 
(1:19) solution at 298K. 
 
Figure 144 – The average zeta potential distribution calculated using 10 runs for compound 5 (3 mM) in an EtOH: H2O 
(1:19) solution at 298K. 
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Figure 145 – The average zeta potential distribution calculated using 10 runs for a 1:1 mixture of compound 3 and 5 
(total 3 mM) in an EtOH: H2O (1:19) solution at 298K. 
Table 20 – The average zeta potential distribution calculated using 10 runs for compounds 4, 5 and a mixture of 3 and 5 
at 3 mM, in an EtOH: H2O (1:19) solution at 298K. 
Compound Mean Zeta Potential (mV) 
3 -14.40 
4 - 32.05 
5 - 53.75 
3 and 5 - 43.00 
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6.10 Critical micelle concentration 
 
Figure 146 – Calculation of CMC for compound 3 in an EtOH: H2O 1:19 mixture using surface tension measurements. 
 
Figure 147 – Calculation of CMC for compound 4 in an EtOH: H2O 1:19 mixture using surface tension measurements. 
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Figure 148 – Calculation of CMC for compound 5 in an EtOH: H2O 1:19 mixture using surface tension measurements. 
Table 21 – Overview of CMC and surface tension (obtained at CMC) measurements for compounds 3-5 at 25°C 
Compound CMC (mM) Surface tension at CMC (mN/m) 
3 24.98 53.70 
4 6.00 56.87 
5 4.24 57.70 
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6.11 Low level in-silico modelling 
 
Figure 149 – Electrostatic potential map calculated for the anionic component of 3. Emax and Emin values depicted in the 
Figure legends are given in kJ/mol. 
 
Figure 150 – Electrostatic potential map calculated for the anionic component of 4. Emax and Emin values depicted in the 
Figure legends are given in kJ/mol. 
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Figure 151 – Electrostatic potential map calculated for the anionic component of 5. Emax and Emin values depicted in the 
Figure legends are given in kJ/mol. 
 
Figure 152 – Electrostatic potential map calculated for compound 6. Emax and Emin values depicted in the Figure legends 
are given in kJ/mol. 
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Figure 153 – Electrostatic potential map calculated for compound 7. Emax and Emin values depicted in the Figure legends 
are given in kJ/mol. 
 
Figure 154 – Electrostatic potential map calculated for compound 8. Emax and Emin values depicted in the Figure legends 
are given in kJ/mol. 
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Figure 155 – Electrostatic potential map calculated for compound 9. Emax and Emin values depicted in the Figure legends 
are given in kJ/mol. 
 
Figure 156 – Electrostatic potential map calculated for compound 10. Emax and Emin values depicted in the Figure legends 
are given in kJ/mol. 
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Table 22 – Electrostatic potential calculated for compounds 3-10.  
Compound Emax (kJ/mol) Emin (kJ/mol) 
3 35.8994 -716.3030 
4 80.8152 -707.3240 
5 69.9097 -719.4140 
6 180.6490 -247.7910 
7 236.6470 -209.2530 
8 200.5310 -271.9090 
9 258.5900 -261.7770 
10 146.2110 -256.9050 
 
